Neurovascular — Net Sales
Stryker Neurovascular — Net Sales increased by 5.4% to $1.05B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 59.6%, from $658.00M to $1.05B. Over 3 years (FY 2021 to FY 2024), Neurovascular — Net Sales shows an upward trend with a 3.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing adoption of the company's neurovascular technologies and successful expansion in the stroke intervention market, while a decrease may signal increased competition or reduced procedure volumes.
Detailed definition
This metric represents the total revenue generated from the sale of neurovascular products, including embolic coils, ste...
Peer comparison
Comparable to neurovascular or interventional neurology revenue segments reported by major medical device peers like Medtronic or Penumbra.
syk_segment_vascular_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $602.00M | $590.00M | $606.00M | $602.00M | $612.00M | $588.00M | $598.00M | $568.00M | $622.00M | $622.00M | $640.00M | $620.00M | $654.00M | $658.00M | $682.00M | $812.00M | $996.00M | $1.05B |
| QoQ Change | — | -2.0% | +2.7% | -0.7% | +1.7% | -3.9% | +1.7% | -5.0% | +9.5% | +0.0% | +2.9% | -3.1% | +5.5% | +0.6% | +3.6% | +19.1% | +22.7% | +5.4% |
| YoY Change | — | — | — | — | +1.7% | -0.3% | -1.3% | -5.6% | +1.6% | +5.8% | +7.0% | +9.2% | +5.1% | +5.8% | +6.6% | +31.0% | +52.3% | +59.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's neurovascular — net sales?
- Stryker (SYK) reported neurovascular — net sales of $1.05B in Q3 2025.
- How has Stryker's neurovascular — net sales changed year-over-year?
- Stryker's neurovascular — net sales increased by 59.6% year-over-year, from $658.00M to $1.05B.
- What is the long-term trend for Stryker's neurovascular — net sales?
- Over 3 years (2021 to 2024), Stryker's neurovascular — net sales has grown at a 3.2% compound annual growth rate (CAGR), from $2.38B to $2.61B.
- What does neurovascular — net sales mean?
- The total revenue earned from selling medical devices used for neurovascular procedures.